Skip to main content
. 2017 Jun 30;8:696. doi: 10.3389/fimmu.2017.00696

Table 5.

Median and interquartile ranges for the measured concentrations of chemokines and growth factors in human milk.

Location IL8 Chemokines
Growth factors
GROα MCP1 MIP1β GCSF GMCSF EGF
ETU 54.01 (27.55–152.11)ad 5.63 (3.14–11.75)ad 132.62 (49.71–338.41)ab 24.75 (14.53–57.33)ad 79.91 (43.77–134.61)a 8.63 (2.80–12.16) 4.65 (3.63–5.70)ac
GBR 59.56 (44.44–167.65)a 4.19 (1.72–8.05)ab 175.50 (70.43–612.74)ab 23.01 (11.46–47.96)ab 51.38 (32.08–99.01)ab 9.99 (9.99–9.99) 3.97 (3.51–5.24)ab
GBU 98.52 (36.06–278.61)a 1.36 (0.71–3.98)bc 147.31 (69.24–465.11)ab 9.48 (5.50–16.84)bc 48.19 (24.53–248.00)ab 13.44 (2.33–24.55) 3.53 (2.78–4.95)ab
GN 6.74 (2.29–17.36)b 0.27 (0.05–0.74)c 126.00 (45.79–260.11)ab 4.24 (2.71–9.15)ce 47.10 (33.76–63.58)ab 23.36 (8.18–42.91) 3.20 (2.21–4.11)b
KE 85.62 (59.15–228.34)a 8.96 (3.00–13.75)a 252.51 (109.92–807.72)a 33.11 (19.38–75.79)a 47.32 (17.45–87.68)ab 10.39 (9.58–11.21) 4.95 (4.10–6.12)ac
PE 67.90 (30.30–143.28)ac 11.01 (3.78–15.02)ab 148.70 (66.41–308.81)ab 14.24 (6.74–28.35)bd 50.20 (13.72–125.33)ab 11.84 (1.79–21.89) 4.19 (3.68–4.62)ab
SP 72.08 (27.73–183.59)ac 6.19 (3.61–10.15)ad 156.57 (59.10–307.49)ab 30.70 (15.17–74.08)ad 18.33 (4.88–59.06)bd 12.87 (0.44–23.83) 5.96 (4.73–6.85)cd
SW 11.66 (4.12–23.24)b 1.31 (0.54–5.71)bde 35.18 (18.60–231.82)b 9.42 (3.01–24.23)bc 1.29 (0.88–2.97)c nd 8.29 (6.12–10.78)d
USC 22.30 (10.94–27.20)bcd 3.82 (0.95–7.19)ab 52.60 (24.19–142.64)ab 19.12 (3.41–31.09)abd 3.13 (1.94–6.51)cd nd 9.42 (6.22–10.55)d
USW 5.19 (2.57–12.19)b 0.34 (0.21–0.73)ce 14.31 (12.33–127.92)b 2.85 (1.37–7.68)e 0.85 (0.18–1.36)c nd 6.85 (5.76–8.51)d

p-value* <0.001 <0.001 <0.001 <0.001 <0.001 0.496 <0.001

Concentrations of GROα and EGF are expressed as micrograms per liter and the concentrations of other chemokines and growth factors as nanograms per liter.

Results are expressed as median (IQR). nd, below detection limit.

ETU, urban Ethiopia; GBR, rural Gambia; GBU, urban Gambia; GN, Ghana; KE, Kenya; PE, Peru; SP, Spain; SW, Sweden; USC, USA/California; USW, USA/Washington; EGF, epidermal growth factor; GCSF, granulocyte colony-stimulating factor; GMCSF, granulocyte–macrophage colony-stimulating factor.

*Kruskal–Wallis test. Different caption letters mean statistical differences when the post hoc pairwise comparison Nemenyi test was done.

HHS Vulnerability Disclosure